Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus

V. Anna Gyarmathy, Alan Neaigus, Nan Li, Eszter Ujhelyi, Irma Caplinskiene, Saulius Caplinskas, Carl A. Latkin

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    The aim of this study was to assess the prevalence and correlates of disclosure to network members of being hepatitis C virus (HCV)- or human immunodeficiency virus (HIV)-infected among injecting dyads of infected injection drug users (IDUs) in Budapest, Hungary and Vilnius, Lithuania,. Multivariate generalized estimating equations (GEE) were used to assess associations. Very strong infection disclosure norms exist in Hungary, and HCV disclosure was associated with using drugs and having sex within the dyad. Non-ethnic Russian IDUs in Lithuania were more likely to disclose HCV infection to non-Roma, emotionally close and HCV-infected network members, and to those with whom they shared cookers, filters, drug solutions or rinse water or got used syringes from, and if they had fewer non-IDU or IDU network members. Ethnic Russian Lithuanian IDUs were more likely to disclose HCV if they had higher disclosure attitude and knowledge scores, 'trusted' network members, and had lower non-injecting network density and higher injecting network density. HIV-infected Lithuanian IDUs were more likely to disclose to 'trusted' network members. Disclosure norms matched disclosure behaviour in Hungary, while disclosure in Lithuania to 'trusted' network members suggests possible stigmatization. Ongoing free and confidential HCV/HIV testing services for IDUs are needed to emphasize and strengthen disclosure norms, and to decrease stigma.

    Original languageEnglish
    Pages (from-to)32-42
    Number of pages11
    JournalScandinavian Journal of Infectious Diseases
    Volume43
    Issue number1
    DOIs
    Publication statusPublished - Jan 2010

    Fingerprint

    Disclosure
    Drug Users
    Hepacivirus
    HIV
    Lithuania
    Infection
    Injections
    Hungary
    Stereotyping
    Syringes
    Virus Diseases
    Pharmaceutical Preparations
    Water

    ASJC Scopus subject areas

    • Microbiology (medical)
    • Immunology and Microbiology(all)
    • Infectious Diseases

    Cite this

    Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus. / Gyarmathy, V. Anna; Neaigus, Alan; Li, Nan; Ujhelyi, Eszter; Caplinskiene, Irma; Caplinskas, Saulius; Latkin, Carl A.

    In: Scandinavian Journal of Infectious Diseases, Vol. 43, No. 1, 01.2010, p. 32-42.

    Research output: Contribution to journalArticle

    @article{1fe068688cbc4e46ba0129236a0f0669,
    title = "Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus",
    abstract = "The aim of this study was to assess the prevalence and correlates of disclosure to network members of being hepatitis C virus (HCV)- or human immunodeficiency virus (HIV)-infected among injecting dyads of infected injection drug users (IDUs) in Budapest, Hungary and Vilnius, Lithuania,. Multivariate generalized estimating equations (GEE) were used to assess associations. Very strong infection disclosure norms exist in Hungary, and HCV disclosure was associated with using drugs and having sex within the dyad. Non-ethnic Russian IDUs in Lithuania were more likely to disclose HCV infection to non-Roma, emotionally close and HCV-infected network members, and to those with whom they shared cookers, filters, drug solutions or rinse water or got used syringes from, and if they had fewer non-IDU or IDU network members. Ethnic Russian Lithuanian IDUs were more likely to disclose HCV if they had higher disclosure attitude and knowledge scores, 'trusted' network members, and had lower non-injecting network density and higher injecting network density. HIV-infected Lithuanian IDUs were more likely to disclose to 'trusted' network members. Disclosure norms matched disclosure behaviour in Hungary, while disclosure in Lithuania to 'trusted' network members suggests possible stigmatization. Ongoing free and confidential HCV/HIV testing services for IDUs are needed to emphasize and strengthen disclosure norms, and to decrease stigma.",
    author = "Gyarmathy, {V. Anna} and Alan Neaigus and Nan Li and Eszter Ujhelyi and Irma Caplinskiene and Saulius Caplinskas and Latkin, {Carl A.}",
    year = "2010",
    month = "1",
    doi = "10.3109/00365548.2010.513064",
    language = "English",
    volume = "43",
    pages = "32--42",
    journal = "Scandinavian Journal of Infectious Diseases",
    issn = "0036-5548",
    publisher = "Informa Healthcare",
    number = "1",

    }

    TY - JOUR

    T1 - Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus

    AU - Gyarmathy, V. Anna

    AU - Neaigus, Alan

    AU - Li, Nan

    AU - Ujhelyi, Eszter

    AU - Caplinskiene, Irma

    AU - Caplinskas, Saulius

    AU - Latkin, Carl A.

    PY - 2010/1

    Y1 - 2010/1

    N2 - The aim of this study was to assess the prevalence and correlates of disclosure to network members of being hepatitis C virus (HCV)- or human immunodeficiency virus (HIV)-infected among injecting dyads of infected injection drug users (IDUs) in Budapest, Hungary and Vilnius, Lithuania,. Multivariate generalized estimating equations (GEE) were used to assess associations. Very strong infection disclosure norms exist in Hungary, and HCV disclosure was associated with using drugs and having sex within the dyad. Non-ethnic Russian IDUs in Lithuania were more likely to disclose HCV infection to non-Roma, emotionally close and HCV-infected network members, and to those with whom they shared cookers, filters, drug solutions or rinse water or got used syringes from, and if they had fewer non-IDU or IDU network members. Ethnic Russian Lithuanian IDUs were more likely to disclose HCV if they had higher disclosure attitude and knowledge scores, 'trusted' network members, and had lower non-injecting network density and higher injecting network density. HIV-infected Lithuanian IDUs were more likely to disclose to 'trusted' network members. Disclosure norms matched disclosure behaviour in Hungary, while disclosure in Lithuania to 'trusted' network members suggests possible stigmatization. Ongoing free and confidential HCV/HIV testing services for IDUs are needed to emphasize and strengthen disclosure norms, and to decrease stigma.

    AB - The aim of this study was to assess the prevalence and correlates of disclosure to network members of being hepatitis C virus (HCV)- or human immunodeficiency virus (HIV)-infected among injecting dyads of infected injection drug users (IDUs) in Budapest, Hungary and Vilnius, Lithuania,. Multivariate generalized estimating equations (GEE) were used to assess associations. Very strong infection disclosure norms exist in Hungary, and HCV disclosure was associated with using drugs and having sex within the dyad. Non-ethnic Russian IDUs in Lithuania were more likely to disclose HCV infection to non-Roma, emotionally close and HCV-infected network members, and to those with whom they shared cookers, filters, drug solutions or rinse water or got used syringes from, and if they had fewer non-IDU or IDU network members. Ethnic Russian Lithuanian IDUs were more likely to disclose HCV if they had higher disclosure attitude and knowledge scores, 'trusted' network members, and had lower non-injecting network density and higher injecting network density. HIV-infected Lithuanian IDUs were more likely to disclose to 'trusted' network members. Disclosure norms matched disclosure behaviour in Hungary, while disclosure in Lithuania to 'trusted' network members suggests possible stigmatization. Ongoing free and confidential HCV/HIV testing services for IDUs are needed to emphasize and strengthen disclosure norms, and to decrease stigma.

    UR - http://www.scopus.com/inward/record.url?scp=78650257658&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=78650257658&partnerID=8YFLogxK

    U2 - 10.3109/00365548.2010.513064

    DO - 10.3109/00365548.2010.513064

    M3 - Article

    VL - 43

    SP - 32

    EP - 42

    JO - Scandinavian Journal of Infectious Diseases

    JF - Scandinavian Journal of Infectious Diseases

    SN - 0036-5548

    IS - 1

    ER -